Literature DB >> 3100962

Association of phosphorylation of the T3 antigen with immune activation of T lymphocytes.

D Cantrell, A A Davies, M Londei, M Feldman, M J Crumpton.   

Abstract

In human T lymphocytes the antigen receptor (Ti) is associated non-covalently on the cell surface with the invariant T3 antigen which comprises 3 chains: two glycosylated polypeptides of relative molecular mass 26,000 (Mr 26K) and 21K (gamma and delta) and one non-N-glycosylated polypeptide of Mr 19K (epsilon). The proposed function of T3 is to transduce the activation signals delivered via the antigen receptor. Recently we have shown that phorbol esters, which stimulate protein kinase C, can induce phosphorylation of the gamma subunit of the T3 antigen. But the critical question is whether T3 phosphorylation occurs as a normal consequence of immune activation of T lymphocytes. In this respect, it has been shown that immune stimulation of murine T cells results in phosphorylation of Ti-associated polypeptides that may be the functional analogues of the human T3 antigen. We have therefore monitored T3 phosphorylation after exposure of human T cells to antigen or phytohaemagglutinin (PHA). The data show that both stimuli initiate phosphorylation of the gamma subunit of the T3 antigen which indicates that T3 phosphorylation is a physiological response to immune activation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3100962     DOI: 10.1038/325540a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  19 in total

1.  CD3 and CD2 antigen-mediated CD3 gamma-chain phosphorylation in permeabilized human T cells. Regulation by cytosolic phosphatases.

Authors:  D R Alexander; M H Brown; A L Tutt; M J Crumpton; E Shivnan
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

2.  Activation of human T lymphocytes: differential effects of CD3- and CD8-mediated signals.

Authors:  Y Samstag; F Emmrich; T Staehelin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

3.  Human CD2 is functional in CD2 transgenic mice.

Authors:  E Monostori; G Lang; D Kioussis; D A Cantrell; R Zamoyska; M H Brown; M J Crumpton
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

4.  CD2 expression and function in lepromatous leprosy.

Authors:  L Wong; P Salgame; V K Torigian; T H Fu; T H Rea; R L Modlin
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

5.  Human immunodeficiency virus type 2 produces a defect in CD3-gamma gene transcripts similar to that observed for human immunodeficiency virus type 1.

Authors:  I Segura; C Delmelle-Wibaut; M Janssens; Y Cleuter; A van den Broeke; R Kettmann; K E Willard-Gallo
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

6.  Phosphorylation and down-regulation of CD4 and CD8 in human CTLs and mouse L cells.

Authors:  J P DiSanto; J S Klein; N Flomenberg
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

7.  A method for measuring protein kinase C activity in permeabilized T lymphocytes by using peptide substrates. Evidence for multiple pathways of kinase activation.

Authors:  D R Alexander; J D Graves; S C Lucas; D A Cantrell; M J Crumpton
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

Review 8.  T cell targeting in cancer therapy.

Authors:  R L Bolhuis; E Sturm; E Braakman
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

9.  Early events of human T lymphocyte activation are associated with type I protein kinase A activity.

Authors:  D Laxminarayana; A Berrada; G M Kammer
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

10.  Modulation of cellular processes by H7, a non-selective inhibitor of protein kinases.

Authors:  J S Nixon; S E Wilkinson; P D Davis; A D Sedgwick; J Wadsworth; D Westmacott
Journal:  Agents Actions       Date:  1991-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.